← All stocks

Sonoma Pharmaceuticals, Inc.

SNOA Net buying
CIK 0001367083 #5371 in the set updated 22 Sep 2026
Bought (120 mo)
$125.37K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$125.37K
+$125.37K against sales at will

By person

13 insiders · 25 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Miller Robert E
Former CFO
$86.82K (15)
+$86.82K
103,556
$424.54K
+56.3%
Schutz James J
Former CEO and Former Director
$30.24K (8)
+$30.24K
35,858
$147.00K
+451.2%
Umscheid Marc
Chief Strategy/Mkt Officer
$8.30K (2)
+$8.30K
3,392
$13.91K
Thornton Bruce
Executive VP and COO
154,411
$633.02K
+18,616%
Trombly Amy Moss
Chief Executive Officer
153,586
$629.64K
DVONCH JEROME J
Chief Financial Officer
84,595
$346.81K
+172.8%
Birnbaum Jay E
Director
51,659
$211.78K
+958.4%
MCLAUGHLIN JOHN
Director
48,728
$199.77K
+642.1%
Harrison Russell Joseph
Director
46,520
$190.71K
+717.9%
BARBARI SHARON
Director
43,417
$177.99K
+733.5%
Dal Poggetto John
Controller
15,000
$61.49K
Northey Robert Allen
Exe. VP of Research and Dev.
8,082
$33.13K
Edwards Robert Grant
Chief Financial Officer
2,609
$10.70K

No percentages here. This company's share count has moved by a factor of 3.6 over the window, from 1,339,170 to 4,785,801 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Miller Robert E
13 Mar 2018
Chief Financial Officer
Buy indirect
1,200
$4.10
$4.92K
Miller Robert E
12 Mar 2018
Chief Financial Officer
Buy indirect
1,200
$4.03
$4.84K
Miller Robert E
12 Mar 2018
Chief Financial Officer
Buy indirect
1,200
$4.03
$4.84K
Miller Robert E
9 Mar 2018
Chief Financial Officer
Buy indirect
1,200
$3.90
$4.68K
Schutz James J
8 Mar 2018
Chief Executive Officer
Buy
2,473
$3.99
$9.87K
Schutz James J
30 Nov 2017
Chief Executive Officer
Buy
345
$4.95
$1.71K
Schutz James J
29 Nov 2017
Chief Executive Officer
Buy
400
$5.03
$2.01K
Miller Robert E
29 Nov 2017
Chief Financial Officer
Buy indirect
1,290
$5.02
$6.48K
Miller Robert E
29 Nov 2017
Chief Financial Officer
Buy indirect
500
$5.03
$2.52K
Schutz James J
24 Nov 2017
Chief Executive Officer
Buy
254
$5.05
$1.28K
Miller Robert E
21 Nov 2017
Chief Financial Officer
Buy indirect
500
$5.04
$2.52K
Miller Robert E
21 Nov 2017
Chief Financial Officer
Buy indirect
1,500
$5.03
$7.55K
Schutz James J
10 Aug 2017
Chief Executive Officer
Buy
929
$5.46
$5.07K
Umscheid Marc
10 Aug 2017
Chief Strategy/Mkt Officer
Buy
600
$5.31
$3.19K
Miller Robert E
10 Aug 2017
Chief Financial Officer
Buy indirect
2,264
$5.30
$12.00K
Miller Robert E
9 Mar 2017
Chief Financial Officer
Buy indirect
250
$7.14
$1.79K
Miller Robert E
9 Mar 2017
Chief Financial Officer
Buy indirect
250
$6.96
$1.74K
Miller Robert E
9 Mar 2017
Chief Financial Officer
Buy indirect
250
$6.97
$1.74K
Miller Robert E
8 Mar 2017
Chief Financial Officer
Buy indirect
750
$6.97
$5.23K
Miller Robert E
8 Mar 2017
Chief Financial Officer
Buy indirect
250
$6.81
$1.70K
Umscheid Marc
6 Mar 2017
Chief Strategy/Mkt Officer
Buy
750
$6.82
$5.12K
Schutz James J
3 Mar 2017
Chief Executive Officer
Buy
104
$6.75
$702.00
Schutz James J
3 Mar 2017
Chief Executive Officer
Buy
696
$6.78
$4.72K
Schutz James J
8 Dec 2016
Chief Executive Officer
Buy
1,000
$4.88
$4.88K
Miller Robert E
8 Dec 2016
Chief Financial Officer
Buy indirect
5,000
$4.86
$24.30K

What was left out

Form 4 filings counted 118
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 602,426
History held since 30 Nov 2016